Why Is Diagnostic Imaging System Usage Rising in Cardiology Departments?

Diagnostic Imaging Systems

According to the International Diabetes Federation (IDF) Diabetes Atlas Ninth edition 2019, approximately 700 million people within the age group of 20–79 years will be living with diabetes by 2045. The report also says that around 374 million people are at an increased risk of developing type 2 diabetes. Furthermore, the World Health Organization (WHO) states that cancer caused around 10 million deaths in 2020. The WHO also forecasts that by 2030, cardiovascular diseases (CVDs) related deaths will rise over 23.6 million. The increasing incidence of such chronic diseases is augmenting the need for diagnostic imaging systems.

As these diseases are highly prevalent among the elderly population, the booming geriatric population will fuel the diagnostic imaging systems market at a CAGR of 5.8% during 2020–2030. The market was valued at $38.9 billion in 2019 and it is projected to reach a revenue of $70.0 billion by 2030. As per the World Population Ageing 2019 report published by the United Nations (UN), the population of people aged 65 years or above will grow to 1.5 billion by 2050. Old people require extensive care, as they are highly susceptible to chronic illnesses, owing to their low immunity levels.

Owing to the burgeoning need for diagnostic imaging systems, companies such as Shenzhen Mindray Bio-Medical Electronics Co. Ltd., General Electric Company, Samsung Electronics Co. Ltd., Canon Inc., Esaote S.p.A., Siemens AG, Analogic Corporation, Carestream Health Inc., and FUJIFILM Holdings Corporation are focusing on introducing advanced products that provide high-quality imaging in healthcare units and quick and accurate results to patients. For instance, in December 2019, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. introduced a comprehensive and dedicated solution to ultrasound imaging— DC-90 with X-Insight. This system assists in improving the diagnostic capabilities and enhancing the clinical workflow.

Currently, diagnostic imaging systems manufacturers are focusing on producing X-ray imaging systems, owing to the extensive use of these systems in various medical application areas, such as dentistry, orthopedics, and cardiology. Whereas, in the coming years, manufacturers will be selling nuclear imaging systems at a rapid pace, due to the surging cases of cancer. These systems are being increasingly adopted for cancer staging and treatment. Additionally, manufacturers are also involved in the production of ultrasound systems, computed tomography (CT) scanners, and magnetic resonance imaging (MRI) systems.

Different types of diagnostic imaging systems are used in application areas such as cardiology, obstetrics/gynecology (OB/GYN), oncology, ophthalmology, neurology, dentistry, urology, and orthopedics. In the coming years, these systems will be mostly used in the field of cardiology, owing to the high prevalence of CVDs worldwide. According to the WHO, CVDs account for over 17.9 million deaths every year, globally. The surging cases of CVDs can be owed to the risk factors such as diabetes, hypertension, obesity, and smoking.

According to P&S Intelligence, North America dominated the diagnostic imaging systems market in the recent past, due to the surging incidence of chronic disorders and soaring healthcare expenditure in the region. Moreover, the presence of a large number of modern diagnostic centers and hospitals also augmented the use of such systems in North America. Whereas, Asia-Pacific is expected to adopt these systems at the highest rate in the foreseeable future. This can be ascribed to the rising prevalence of chronic ailments and the booming number of diagnostic imaging centers across the region.

Thus, the escalating cases of chronic diseases and booming geriatric population will augment the need for diagnostic imaging systems in the coming years.

Disposable Plastic Blood Bag Industry Insights, Leading Players and Forecast Report 2030

Disposable Plastic Blood Bags Market

The disposable plastic blood bags market will power at a rate of 6.1% in the years to come, to touch USD 530.0 million by 2030. Not just blood, they support in the in the separation of white blood cells, plasma, red blood cells, platelets, and cryoprecipitate, for treatment of numerous disorders, which is the main reason of their increasing sales all over the world.

Single disposable plastic blood bag was the most used alternative in the past. This has a lot to do with the increase in the number of transfusion procedures, increase in the cases of trauma and accidents, and increase in the incidence of numerous hematologic illnesses.

Hospitals mad the most use of these bags, with a share of over 60% in the past. These come good for collection of blood and transfusion in hospitals as a result of their numerous useful qualities and biocompatibility characteristics.

The requirement for blood supply in hospitals has augmented as a result of the increasing prevalence of chronic ailments, for example cancer, and the increasing volume of surgical procedures.

These factors have a lot to do with healthcare industry expansion and the increase in the hospital and health clinic count. The bags provide a safe environment for the transportation and storage of blood and its components.

Disposable plastic blood bags are majorly sold with the help of tender-based channel. Producers’ strategies must comprise sales with the help of tenders in the healthcare industry.

With the support of a competitive bidding procedure, a tender comes good in the bulk obtaining of services and products.

Tender-based procurements are often used for the purpose of reducing the cost through the entire journey of the contract. As a result of the price competition, the acceptance of this technique for lowering the cost would go up significantly.

Apart from decreasing the inadequacies brought on by segmented distribution systems, it often produces economies of scale.

North American disposable plastic blood bags market will continue to be the regional leader in the years to come. The increasing use of hematological and pathological tests, along with the high prevalence of chronic ailments, offers lucrative growth prospects.

Also, the existence of a well-resourced healthcare infra, snowballing donation activities, and attempts of the government for promoting the usage of these bags for preventing HAI, which are a key risk with glass bottles of blood, impact the growth in a positive manner.

There is a sharp rise in the elderly population all over the world, and because of this, the demand for disposable plastic blood bags will be impacted in a positive manner.

The Brain, Head, and Neck Category To Observe Fastest Growth In The MRI Systems Industry

MRI Systems Market

As per a report by P&S Intelligence, the MRI systems market generated a value of USD 8,924 million in 2022, and it will reach USD 14,880 million, growing at a 6.60% compound annual growth rate, by 2030.

The growth in the industry is credited to the increasing consciousness of the early diagnosis of diseases, growing support from the government for MRI, the mounting elderly population, the rising incidence of chronic illnesses, and advancements in technology in magnetic resonance imaging.

The constant research and development have enabled the production of advanced magnetic resonance imaging systems in the past few years, which have improved output, test times, and image quality. Some of the main developments in this field are hybrid MRIs and MRI-compatible devices.

Based on architecture, in 2022, the closed MRI category accounted for the larger share, at approximately 78%. This is credited to the fact that closed MRIs provide more-accurate scans of a higher resolution compared to open MRIs.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=mri-market

Based on type, the mobile category will advance at a higher growth rate, of 7.2%, in the years to come. This is credited to the fact that portable variants require lesser pre-installation expenses and decrease the travel requirements for patients.

Based on field strength, the high category will continue to be dominant, with a significant share by 2030. This is attributed to the high accuracy, spatial resolution, and efficiency advantages of high-field-strength MRI machines.

Based on application, the brain, head, and neck category will observe the fastest growth in the MRI systems market, with a growth rate of 7%, in the years to come. This is ascribed to the increasing prevalence of traumatic brain and neck injuries across the world.

In 2022, hospitals and clinics accounted for the largest share, of approximately 81%, in the industry. This is primarily ascribed to the large number of patients that visits hospitals and clinics for medical care.

The support for magnetic resonance imaging is increasing as governments all over the world are offering financial support to increase the implementation of these scanners in healthcare settings.

In 2022, the North American MRI system industry accounted for the largest share, at 38%. The high healthcare expenses and developed healthcare facilities are the main factors driving the regional industry growth. Furthermore, the increasing elderly population in North America is boosting the requirement for diagnostic imaging.

Hence, with the increasing consciousness of early diagnosis of diseases, advancement of technology in magnetic resonance imaging, and the increasing support for MRI from the government globally, the MRI systems industry will continue to grow in the years to come.

Ventilator Industry Insights, Top Players and Demand Forecast Report 2030

Ventilator Market

The ventilator market will grow at a rate of 7.1% in the years to come, to touch USD 2,887.32 million by 2030. This growth has a lot to do with the increasing cases of chronic diseases, such as COPD and asthma globally.

Critical care dominated the industry. This is because of the COVID-19 virus, which has affected a lot of global population. This results in the enormous necessity for critical care, because of a lot of hospitalizations.

Smoking is one of the key reasons of COPD. There are a lot of tobacco users in the low or middle-income nations. As per the CDC, cigarette smoking is a major cause of ailment, debility, and death in the U.S., and it causes for over 480,000 fatalities every year.

Therefore, the necessity for critical care increases, which drives the demand for ventilators in this category.

Standard ventilators had the largest share, of above 65%, in the recent past. The development in healthcare facilities and hospitals, and the efficiency of ventilators in variety of applications in numerous care delivery settings will have a favorable effect on the growth of the market in this category.

Adults dominate the ventilator market, as per a report by P&S Intelligence. This is because they are more susceptible to ailments such as asthma, COPD, and respiratory diseases. Furthermore, the increasing count of smokers and the growing elderly population are powering the category growth.

Invasive ventilators had the largest share in the industry with about 60%. This has a lot to do with the increasing number of ICU beds, which has ventilators, snowballing occurrence of respiratory illness, and a growing count of surgical procedures happening, all over the world.

There is also an increase in the number of hospital admissions, mainly because of the outbreak of the pandemic. These types of ventilators are a major component of intensive care units and emergency for treating ill patients.

North America dominated the market with over 30% share, in 2021. This is because of the increasing prevalence of respiratory ailments like bronchitis and asthma.

COPD is perhaps the biggest threat for the people of this region. Likewise, as a result of the advanced healthcare infra in Canada and the U.S., improved ventilator systems are used more often in the region. For example, as per data made available, there were 77,000 ventilators in the hospitals of the country hospitals as of March 2020 and over 8,000 ventilators in the nursing homes of America.

It is due to the increasing count of hospital beds, the demand for ventilators will increase even further by the end of this decade.

Point-of-Care Ultrasound Device Industry is Dominated by Europe

Point-of-Care Ultrasound Device Market

As stated in a report by P&S Intelligence, a market research firm, the PoCUS devices market will grow at a rate of 7.9% in the years to come, to reach USD 4,546.5 million by 2030.

The increasing healthcare costs, increasing elderly population, emerging healthcare infra, and growing occurrence of chronic diseases will propel the growth of the industry.

Diagnostic devices will have the larger share in the industry. This has a lot to do with the growing usage of these devices in pericardial effusion, ultrasound for left ventricular systolic function, and severe mitral regurgitation, in addition to pneumothorax, pleural effusion, and pulmonary edema.

Emergency medicine dominated the market. This is because of the increasing requirement for cutting-edge PoCUS devices for critical care worldwide. For example, bedside ultrasound is an important tool for physicians in critical care environments for getting immediate clinical info, advance patient safety, surge efficiency, and reduce the probabilities of complications.

PoCUS devices are used more and more as time-saving tools that surge the competence, while increasing the safety of patients, particularly for the aged people. For the reason that elderly patients have more problems and a higher rate of mortality than the younger people, the usage of PoCUS devices is highly endorsed for them.

Tech progressions in computing applications, electronics, and transducers have transformed ultrasound devices recently, resulting in their increasing acceptance.

Expansions in transducer materials and designs of array have brought about greater bandwidths, with an upgradation in the spatial and contrast resolutions. These progressions have, resulted in new imaging modes, which makes the most of the non-linear performance of tissues and micro-bubble contrast agents. Therefore, tech progressions are trending in the industry, in the recent times.

Europe had the highest revenue share in the point-of-care ultrasound devices market , and it will be like this in the years to come. The regional market is powered by the high incidence of chronic ailments, growing healthcare spending, and progressions in technology.

Also, the booming elderly population is driving the growth of the industry in Europe, as it is more vulnerable to diseases.

As per the World Population Ageing 2019, about 140.4 million people were aged 65 years or above in Europe in 2019, and it will reach to a value of 199.9 million by 2050.

The industry is rather fragmented, with the occurrence of more than a few key players. Stalwarts of the market are focusing on strategic partnerships and mergers for being competitive in the market.

It is because of the increasing elderly population, the demand for point-of-care ultrasound devices will continue to grow in the years to come.

Battling and Defeating Cancer With Immunotherapy Drugs

Immunotherapy Drugs Market

It is quite common to find people suffering from cancer. Cancer was once considered untreatable, but it is not the case with all the developments going on in medical science.

Cancer has everything to do with putting bad impact of the body, that’s why the body is not able to recognize the cancer cells and fight with them. In this blog, there will be information about immunotherapy, which is a particularly recent treatment for cancer.

Immunotherapy utilizes the immune system of a person for battling cancer. It usually has fewer side effects than a chemotherapy treatment.

Immunotherapy is done on the basis of immune cells that have the potential of recognizing and killing cancer cells can be produced in the labs and given to patients for the treatment of cancer. Several immunotherapy drugs have got the approval by the FDA or are in the process of clinical trials for determining their efficiency in treating various cancers.

Preparing Immune System To Fight Cancer

Immunotherapies makes use of different methods for battling with cancer cells. There are generally three types of Immunotherapies:

Checkpoint inhibitors- It is that process, which disturbs the system of cancer cell signals dodging the immune system into thinking they’re healthy, exposing them, and get them attacked by the immune system

Cytokines- cytokines helping in regulating and directing the immune system are formulated in a lab and injected into the body in larger dose than that, which are produced naturally in the human body.

Cancer vaccines- These are vaccines which reduce the risk of cancer by launching an open attack on the cancer causing viruses, or might help in the treatment of cancers by motivating the immune system for attacking cancer cells in a precise body part.

Immunotherapy might be put to use alone or in combination with other cancer treatments, for example surgery, chemotherapy, radiation and targeted therapy.

Immunotherapy Vs Chemotherapy

Both immunotherapy and chemotherapy are usually employed treatments of cancer using drugs put a halt or slow the rate of growth of cancerous cells. Though, while chemotherapy drugs attack quickly producing cells all over the body, immunotherapy activates the immune system’s capability to recognize and attack the cells causing cancer.

What are the Benefits of Immunotherapy

Immunotherapies are less common than chemotherapy as a cancer treatment. But these therapies are a treatment option for various cancers.

Immunotherapies can be more comprehensive and less noxious than other treatments used for treating cancer, as they harness the body power to attack the cancer cells rather than inserting chemicals into the body.

Immunotherapies are an active area of research in cancer therapy, and many of the new treatments are waiting to be approved for use for the treatment of cancer.

Due to the increasing prevalence of Chronic diseases around the world, the demand for immunotherapy drugs will further increase in the years to come, and will reach a value of USD 210,752 million by the end of this decade.

 

North America Is Dominating Surgical Sutures Industry

Surgical Sutures Market

The total value of the global surgical sutures market was USD 4.1 billion in 2021, and it will rise at a growth rate of above 5.9% shortly, reaching USD 6.8 billion by 2030, according to P&S Intelligence. This development can be credited to the growing count of medical procedures and the growing occurrence of chronic illnesses throughout the globe.

In recent years, absorbable sutures led the industry, with a market share of above 52%, and the same is also estimated to be in the leading position throughout the forecast period. This is mainly because of its timings, as it takes less time and reduces the count of patient visits to hospitals.

Internal operations regularly use absorbable sutures because they naturally and securely break in the body. Hydrolytic, proteolytic, and enzymatic devices are utilized to degrade these sutures. Reliant on the material used for the process, the breakdown procedure characteristically takes 9 days to 8 weeks. Different materials, polyglycolic acid, including catgut, polylactic acid, and polydioxanone, are utilized to make absorbable sutures.

In 2021, the cardiovascular surgery category had the largest surgical sutures market share, approximately 30.0%, because of the rising occurrence of cardiovascular illnesses. Cardiovascular operations, such as heart transplantation operations, are undertaken to cure difficulties of valvar heart illnesses, ischemic heart illnesses, and congenital heart illnesses.

Surgical procedures involving cardiovascular systems are the most complex and high-risk, necessitating sutures of the highest quality and suitability. An increase in the number of patients with heart disorders leads to a rise in the usage of cardiovascular surgeries, boosting the demand for sutures in the market.

In recent years, the North American region dominated the industry by generating the highest revenue share, of over 40%. This can be credited to the growing elderly populace, the growing count of road accidents, the rising cases of obesity and diabetes, and the growing burn cases in the continent.

Furthermore, the augmented requirement for improved surgical techniques and products, including biocompatible surgical sutures with antimicrobial coatings, is boosting the development of the industry in North America.

Hence, the growing count of medical procedures and the growing occurrence of chronic illnesses throughout the globe are the major factors propelling the surgical sutures market.

Global Sleep Apnea Devices Industry Growth and Future Analysis

Sleep apnea is a condition that affects inhalation and exhalation during sleeping. It often causes snoring. Sleep apnea can easily be identified if you have slept a full night, and still wake up feeling tired.

Common symptoms of Sleep Apnea

If you have experienced loud snoring, episodes in which you stop breathing during sleeping, usually reported by another person monitoring you are common symptoms of sleep apnea. Along with these, gasping for air, awakening with a dry mouth, insomnia, hypersomnia, difficulty in staying attentive being awake, and irritability are sleep apnea symptoms.

Types of Sleep Apnea

Obstructive Sleep Apnea: This condition usually occurs when the muscles of the throat relax.

Central Sleep Apnea: This condition occurs when the brain stops sending proper signals for controlling breathing to muscles.

Complex Sleep Apnea Syndrome: This condition comprises both obstructive sleep apnea and central sleep apnea.

Causes of Sleep Apnea

The changes in the lifestyle and sleeping patterns of people lead to a growing prevalence of obstructive sleep apnea with increasing work stress. In addition, the rising cases of sleep disorders with associated health conditions such as obesity and heart disease lead to the increasing demand for sleep apnea devices.

Sleep Apnea Treatment

The sleep apnea treatment provides ease in opening the airways for better inhalation and exhalation during sleeping. There are numerous devices to treat such conditions. CPAP is a most common technology comprised of numerous mouth appliances, machines, and specially designed machines.

CPAP

CPAP stands for Continuous Positive Airway Pressure. These machines are equipped with a mask that fits over both nose and mouth or only the nose. It blows air at pressure for keeping the airways open during sleep.

Mouth Devices for Sleep Apnea

Mandibular Advancement Device: It is a device that looks similar to a mouth guard worn by athletes. This snaps over both the tooth lower and upper. The hinges keep the lower jaw forward, which makes the tongue and soft palate stable to keep the airways open while asleep.

Tongue Retaining Device: It is similar to a splint that keeps the airway open by holding the tongue in place. Usually, doctors provide it as MAD.

Position Pillows: If you have ever searched for solutions online, then you must have found types of pillows to provide relief. These pillows can be used either the ways with or without a CPAP machine. You may find these pillows in different styles such as wedge shape that lifts the upper body.

Nerve Stimulation Devices

A hypoglossal nerve stimulator is utilized in a condition when the tongue or other tissue falls back and blocks the airway. It is a small size about the size of a pacemaker. Doctors may insert it in the chest through surgery. It can be turned on and off through a remote. This device monitors breathing patterns and sends signals to nerves for controlling muscles, including the tongue.

The major companies operating in the industry are Natus Medical Incorporated, BRAEBON Medical Corporation, Fisher & Paykel Healthcare Limited, ResMed Inc., SLEEPON Inc., Alaxo GmbH, and BMC Medical Co. Ltd.

Therefore, radical shifts in lifestyle, stress, obesity, and cardiac diseases, lead to growing prevalence of sleep disorders.

Boom Expected in Medical Coding Industry in Asia-Pacific in Future

Medical Coding Market

The global medical coding industry was worth $15.2 billion in 2019. As per the estimates of P&S Intelligence, a market research company based in India, the market will advance at a CAGR of 9.6% between 2020 and 2030. Furthermore, the market is predicted to reach a value of $42.4 billion by 2030. The increasing prevalence of insurance frauds and the rising demand for modernizing hospital billing methods are the main factors fueling the growth of the market.

The prevalence of insurance frauds is growing rapidly, especially in the healthcare industry. This is causing huge financial losses for various businesses and organizations. According to the findings of the National Health Care Anti-Fraud Association (NHCAA), the high occurrence rate of insurance frauds is resulting in losses amounting to billions of dollars for companies across the U.S. every year. Furthermore, in the country, nearly $3.6 trillion was spent on various healthcare services in 2018.

This amount included expenditure on medical services and goods, investments related to medical care, public health activities, and net cost of healthcare insurance. This represented billions of health insurance claims, amongst which, a few were found to be fraudulent. Apart from these, the rising requirement for modernizing medical billing procedures is also driving the expansion in the market. The adoption of medical coding systems, particularly the current procedural terminology (CPT) medical code, has made medical billing procedures highly effective.

This medical code has been formulated by the American Medical Association (AMA) for standardizing and facilitating medical billing procedures. There are several alpha-numerical codes present in the coding system, that are developed for describing various services and treatments that doctors perform on their patients. These code sets are defined and put into a database, that is used to bill insurance firms for their services. This billing system helps medical practitioners keep a better track of financial records.

Depending on end user, the medical coding market is divided into diagnostic enters and hospitals. Of these, the hospitals category is predicted to register higher growth in the market in the future years. Medical coding procedures are extensively used by hospitals for revenue management. The rising incidence of chronic diseases throughout the world and the increasing requirement for hospital visits are propelling the advancement of the category in the market.

Globally, the medical coding market is predicted to demonstrate rapid progress in the Asia-Pacific region in the forthcoming years. This will be because of the rising digitization of the records of patients in several regional countries such as South Korea and India and the surging pool of people availing various health insurance services. Additionally, the presence of a large patient population is further boosting the advancement of the market in this region.

Hence, it can be said with full confidence that the market will demonstrate rapid growth all over the world in the years to come, mainly because of the rising digitization of healthcare billing methods, the rising incidence of insurance frauds, and the growing requirement for better and more effective medical billing procedures.

The Evolution Of The Healthcare Ecosystem

Ecosystem of Healthcare Industry

The healthcare ecosystem insights report shelters a comprehensive study of the healthcare sector in the U.K., the U.S., Germany, China, Singapore, France, and Japan.

The development of the industry in the seven countries can be credited to the growing count of cases of chronic illnesses, growing acceptance of healthcare insurance, growing demand for in-vitro diagnostic (IVD) tests, thriving elderly populace, rising gross domestic product (GDP) and healthcare investments, government initiatives, advancing healthcare infrastructure, and fast digitization in the medicinal ecosystem.

Based on type, the cardiovascular and circulatory diseases category, is projected to generate the highest revenue of more than 42.6% in Germany, experiencing a CAGR of 3.3% in the coming few years. This is mainly because cardiovascular disorders (CVDs) are the most widespread chronic diseases in the nation. The cancer category is estimated to be the second-largest category in the German industry, with a 26.5% share, in the coming years.

On the basis of channel, in recent years, the state/local category had the third position in the Japanese industry, accounting for more than 17.4% industry share. This was because fewer healthcare facilities are provided at the state/local level in the nation.

Industry Dynamics

The healthcare sector development in the seven nations is boosted by the rise in the elderly populace, growing demand for IVD tests, digitalization in the healthcare industry, and widescale acceptance of healthcare insurance. The Elderly has a direct link with chronic illnesses, like CVDs, neurological circumstances, and rheumatoid arthritis.

The growing life expectancy and lessening death rates are the main contributors to the growing elderly populace throughout the world. As per the World Bank, the populace of individuals aged 65 years or above grew from 34.2 million in 2017 to 40.1 million in 2021 in Japan and from 13.2 million in 2017 to 19 million in 2021 in France.

Additionally, an analysis by the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) of Japanese people old 75 years and more exposed that more than 65% of these people were living with at least three co-occurring illnesses, like coronary heart disease, hypertension, and peptic ulcers. Since elder people are extremely vulnerable to these ailments, the growing elderly populace in such nations will boost the requirement for medicine and other medical amenities in the coming years.

Furthermore, the rising demand for IVD tests will ease the healthcare sector development in the coming few years. The growing utilization of IVD tests can be credited to their fast and dependable outcomes, smooth information recording capability, to confirm the results, simple repeatability, numerous tests performing ability, and skill to sense an extensive variety of substances in the body.

For example, China is generating a high demand for such tests because of the growing occurrence of chronic diseases among the elderly populace, several of which can be identified and monitored via IVD products. Moreover, the growing acceptance of health insurance guidelines is having a positive effect on market development, as health insurance decreases the financial load on patients.